Evaluating the Impact of National Volume-Based Procurement: Evidence from China

Zeyang Wang ()

MPRA Paper from University Library of Munich, Germany

Abstract: The Volume-Based Procurement (VBP) undertaken by governments significantly influences the healthcare landscape across numerous nations. Initiated in 2018 and broadened in 2019, the National Volume-Based Procurement in China has experienced eight phases of execution throughout key regions. This research utilizes a Difference-in-Differences (DID) framework to assess the effects of centralized procurement on pharmaceutical results. The results indicate that: (1) in the 2018 pilot phase, there was a significant reduction in drug expenditures, an increase in quantities, and a marked decline in prices; and (2) when analyzing the impact of all seven subsequent rounds, both expenditures and prices continued to show significant decreases, although quantities also saw a considerable decline.

Keywords: Volume-Based Procurement (VBP); Pharmaceutical Prices; Difference-in-Differences (DID) (search for similar items in EconPapers)
JEL-codes: C8 H40 I18 (search for similar items in EconPapers)
Date: 2024-12-13
New Economics Papers: this item is included in nep-cna and nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/123015/1/MPRA_paper_123015.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:123015

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().